92
Participants
Start Date
March 22, 2021
Primary Completion Date
April 27, 2023
Study Completion Date
April 27, 2023
University of North Carolina at Chapel Hill, Chapel Hill
Collaborators (1)
GlaxoSmithKline
INDUSTRY
University of North Carolina, Chapel Hill
OTHER